Volume 2, Issue 1 (2021)

1. Yang H-C, Shih Y-S, Liu C-J. Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B. JID. 2017; 216 (Suppl 8): S757,1-8 

2. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546-55. 

3. Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053-2063 

4. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet, 2009;373:582-92. 5. Xiang Y, Chen P, Xia JR, Zhang LP. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies. Genet Mol Res. 2017;16. 6. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264-73.e1. 

7. Olayinka AT, Oyemakinde A, Balogun SM, Ajudua A, Nguku P, Aderinola M, et al. Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey. Am J Trop Med Hyg. 2016;95(4):902-907 

8. Musa B, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B virus infection in Nigeria, 2000- 2013: A systematic review and meta-analysis. Niger J Clin Pract. 2015;18(2):163-72. 

9. Ejeliogu EU, Oguche S, Anejo-okopi JA et al. Prevalence and Laboratory Profile of Hepatitis B Virus co-infected Nigerian Children with HIV infection. International Journal of Tropical Disease and Health, 2014;4(7):773-781